| Literature DB >> 28553952 |
Jacquelyn A Gorman1, Christian Hundhausen2, John S Errett3,4, Amy E Stone3,4, Eric J Allenspach1,5, Yan Ge6, Tanvi Arkatkar1, Courtnee Clough1, Xuezhi Dai1, Socheath Khim1, Kathleen Pestal4, Denny Liggitt7, Karen Cerosaletti2, Daniel B Stetson4, Richard G James1,5, Mohamed Oukka1,4,5, Patrick Concannon6, Michael Gale3,4, Jane H Buckner2, David J Rawlings1,4,5.
Abstract
The single-nucleotide polymorphism rs1990760 in the gene encoding the cytosolic viral sensor IFIH1 results in an amino-acid change (A946T; IFIH1T946) that is associated with multiple autoimmune diseases. The effect of this polymorphism on both viral sensing and autoimmune pathogenesis remains poorly understood. Here we found that human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the risk variant IFIH1T946 exhibited heightened basal and ligand-triggered production of type I interferons. Consistent with those findings, mice with a knock-in mutation encoding IFIH1T946 displayed enhanced basal expression of type I interferons, survived a lethal viral challenge and exhibited increased penetrance in autoimmune models, including a combinatorial effect with other risk variants. Furthermore, IFIH1T946 mice manifested an embryonic survival defect consistent with enhanced responsiveness to RNA self ligands. Together our data support a model wherein the production of type I interferons driven by an autoimmune risk variant and triggered by ligand functions to protect against viral challenge, which probably accounts for its selection within human populations but provides this advantage at the cost of modestly promoting the risk of autoimmunity.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28553952 PMCID: PMC5697900 DOI: 10.1038/ni.3766
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606